EPR Properties beats Q1 EPS by 11 but shares dip 04 as investors eye revenue outlook PLRX Pliant Therapeutics falls 376 percent following narrow Q4 2025 EPS beat with zero quarterly revenue Tango Therapeutics Inc TNGX Stifel Raises Price Target to 40 Amid Strong Conviction in Oncology Pipeline Is Arlo ARLO stock a viable buying opportunity Arlo posts 313 EPS beat topping analyst views Treasury Yield Surge Challenges RiskFree Assumption Opens Doors for FixedIncome Opportunity Wingstop Shares Tumble 12 as Quarterly Earnings Miss Analyst Forecasts SP 500 Edges Higher as Consumer Stocks Rally Energy Drags Webull Corporation Market Speculation Suggests Potential for Significant Growth by 2027 Trump Indicates Iran Nuclear Deal Largely Negotiated Strait of Hormuz Reopening Eyed Americans Dip into Emergency Savings as Gas Prices Strain Household Budgets Everspin Technologies Q1 2026 Earnings EPS Beat Drives Positive Market Response ALTI Q1 2026 Earnings Earnings Beat Despite Negative Market Reaction VABK Q1 2026 Earnings Solid EPS Performance Amid Stable Banking Operations EOSE Q1 2026 Earnings Narrower Loss Surprises Analysts as Energy Storage Momentum Builds PRAX Q1 2026 Earnings EPS Beat Amid Continued RD Focus HLNE Q1 2026 Earnings EPS Beats Estimates Shares Rise US Bancorp USB Edges Higher in Cautious Trading Session SouthState Bank SSB Edges Higher Tests Resistance as Support Holds Outlook Therapeutics Surges 27 Assessing the Move and Key Levels for OTLK Nektar Therapeutics NKTR Holds Steady Near Support as Biotech Sector Awaits Catalysts Corebridge Financial Junior Subordinated Notes CRBD Nudge Lower Amid Steady FixedIncome Sentiment China Urges APEC Cooperation as Commerce Minister Skips Opening Amid Urgent Business SEER Q1 2026 Earnings Slight EPS Beat Amidst Quiet Revenue Disclosure Centessa Pharmaceuticals CNTA Holds Steady Near Key Support After Minimal Movement